Accelerator Facility Launched for Clinical Lab Tests
To help diagnostics start-ups from around the world more rapidly enter the U.S. market, 20/20 GeneSystems is giving access to a CLIA laboratory.
Read MorePosted by Chris Wolski | Sep 29, 2021 | Compliance |
To help diagnostics start-ups from around the world more rapidly enter the U.S. market, 20/20 GeneSystems is giving access to a CLIA laboratory.
Read MorePosted by Toni Mitchell | Sep 24, 2021 | Prostate |
The U.S. Food and Drug Administration (FDA) has authorized marketing of software to assist medical pathologists in detecting areas suspicious for cancer.
Read MorePosted by Chris Wolski | Sep 2, 2021 | Prostate |
During the pandemic, studies have shown many men are missing or delaying routine health screenings, including prostate cancer screenings.
Read MorePosted by Chris Wolski | Sep 1, 2021 | Unknown Origin & Other Cancer Types |
Blood and urine tests could lead to faster and less invasive methods to diagnose and monitor various types of tumors, new research indicates.
Read MorePosted by Chris Wolski | Sep 1, 2021 | Cancer |
New diagnoses of eight common types of cancer significantly declined during most of the first 13 months of the pandemic.
Read More